CD274 and triple-negative breast carcinoma: Activated T cell-derived exosomes were shown to express PD-1 that attenuated PD-L1-triggered immune dysfunction in triple-negative breast cancers, suggestive of the feasibility of attenuating the suppressive TME by modifying the exosome surface with inhibitory immune checkpoint receptors (56).